Should You Buy Morphosys Ag (MOR) Stock Wednesday Morning?

Morphosys Ag (MOR) has fallen Wednesday morning, with the stock declining -3.78% in pre-market trading to 5.34. MOR's short-term technical score of 48 indicates that the stock has traded less bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 128 out of 146 industries, the stock ranks higher than 68% of stocks. Morphosys Ag has fallen 27.17% over the past month, closing at $8.12 on November 1. During this period of time, the stock fell as low as $4.55 and as high as $8.55. MOR has an average analyst recommendation of Buy. The company has an average price target of $11.59.

MOR has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on MOR!

See Full MOR Report

Morphosys Ag has a Long-Term Technical rank of 18. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 82% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, MOR ranks better than 130% of stocks.

Important Dates for Investors in MOR:

-Morphosys Ag is set to release earnings on 2024-02-13. Over the last 12 months, the company has reported EPS of $-4.42. -We do not have a set dividend date for Morphosys Ag at this time. Click Here To Get The Full Report on Morphosys Ag (MOR)